-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Silexion Therapeutics Corp quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2023 to Q2 2025.
- Silexion Therapeutics Corp Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2025 was -$2.51M, a 135% decline year-over-year.
- Silexion Therapeutics Corp Net Cash Provided by (Used in) Operating Activities for the twelve months ending June 30, 2025 was -$10.5M.
- Silexion Therapeutics Corp annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$8.4M, a 85.4% decline from 2023.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)